Ratings Pickles Corporation

Equities

End-of-day quote Japan Exchange Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
1,161 ^JPY	-0.17%		-0.43%	-4.44%

Apr. 16	Pickles Holdings Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending August 31, 2024 and Full Year Ending February 29, 2025	CI
Apr. 16	Pickles Holdings Co.,Ltd. Provides Dividend Guidance for the Year Ending February 28, 2025	CI

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

The stock, which is currently worth 2024 to 0.27 times its sales, is clearly overvalued in comparison with peers.
The company's share price in relation to its net book value makes it look relatively cheap.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company does not generate enough profits, which is an alarming weak point.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
PICKLES CORPORATION	-4.44%	92.01M		-
CHONGQING FULING ZHACAI GROUP CO., LTD.	-1.26%	2.25B		C
AGRANA BETEILIGUNGS-AG	-3.55%	924M		B-
LONTRUE CO., LTD.	+82.00%	710M	-	-
LASSONDE INDUSTRIES INC.	-1.13%	694M	-	D
THAI COCONUT CO.,LTD.	+62.03%	515M		-
CALAVO GROWERS, INC.	-10.34%	469M		C+
TIANYUN INTERNATIONAL HOLDINGS LIMITED	-3.03%	405M	-	-
TUKAS GIDA SANAYI VE TICARET	+10.83%	348M	-	-
CHALKIS HEALTH INDUSTRY CO., LTD	-24.79%	284M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality